Pfizer CEO

Pharmaceutical giant Pfizer Inc. (PFE.N) has announced its intention to acquire Seagen Inc. (SGEN.O) in a $43 billion deal. The acquisition is aimed at reinforcing Pfizer's portfolio of targeted cancer therapies in the face of an expected decline in sales...

Pfizer's Albert Bourla received the Greek top honor by the President of the Hellenic Republic, Katerina Sakellaropoulou, in a special ceremony at the Presidential Palace on Tuesday. The Thessaloniki-born scientist was awarded the Golden Cross of the Order of the...

Pfizer, the international pharmaceuticals giant helmed by Thessaloniki-born Dr. Albert Bourla, made a staggering $36.8 billion on its first-in-the-world coronavirus vaccine last year. First authorized for emergency use in December of 2020, just nine months after the virus began to...

A fourth shot will be needed as the power of the booster wanes, Moderna CEO Stephane Bancel stated on Thursday while addressing a Goldman Sachs healthcare conference. His comments were the first such definitive statement by Moderna regarding the need...

The first long-term study of Pfizer’s Covid-19 vaccine is out -- and the results show that the shot is 100% effective against the coronavirus in those 12 to 15 years of age, it was announced on Monday. Officials from Pfizer...

The pharmaceuticals giant Pfizer has signed a $5.3 billion deal with the United States government to supply its anti-Covid Paxlovid pills to the American people, according to a statement released by the company on Thursday. This is enough to supply...

The Pfizer corporation announced on Tuesday that its officials had inked a licensing agreement which will enable less wealthy nations to distribute its antiviral drug Paxlovid in the form of generic anti-Covid pills. Pfizer, based out of New York City,...

Pfizer's brand-new anti-Covid pill called "Paxlovid" reduces hospitalization and death risk by 89%, the company states as it readies to place the results of its studies before the FDA by the end of November. Taking the pills developed by Pfizer...

Pfizer CEO Albert Bourla said definitively on Friday that people will need another dose of coronavirus vaccine in eight months to a year.